Skip to main content
. 2006 Jan 19;4:4. doi: 10.1186/1477-7819-4-4

Table 3.

Multivariant analysis of effects on overall survival stratified by residual disease after primary surgery.

Variable Harzard 95%CI P value
Age >60 1.26 1.02–1.57 0.03
FIGO stage IV 4.84 2.73–8.57 <0.01
Initial paclitaxel* 0.80 0.71–0.90 <0.01
IP chemotherapy 0.71 0.56–0.90 <0.01

Abbreviation: IP, intraperitoneal; 95%CI, 95% confidential interval; FIGO, International Federation of Gynecology and Obstetrics.

* Paclitaxel as front-line chemotherapy.